RxDoctor Payments DataLook up a doctor →

Jason Austin, DO

Family Medicine · Johnston, RINPI 1013963818

Payments from drug & device makers

$14,761in general payments, 2019–2025

Across 705 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$2K
  • AstraZeneca$2K
  • GSK$1K
  • Pfizer$1K
  • Vanda Pharmaceuticals Inc.$838
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$14,66299%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)108$1,981
Johnson & Johnson64$1,600
AstraZeneca73$1,534
GSK74$1,333
Pfizer59$1,324
Vanda Pharmaceuticals Inc.31$838
E.r. Squibb & Sons, L.L.C.29$546
Novartis22$491
Novo Nordisk21$405
Nestle Healthcare Nutrition Inc.14$309
Astellas Pharma US Inc10$299
Abbott11$298
Amgen13$277
Lundbeck LLC14$254
Teva Pharmaceuticals USA, Inc.11$251
Mylan Specialty L.p.12$239
Tolmar, Inc.21$233
Exact Sciences10$216
Regeneron Healthcare Solutions, Inc.8$164
Biohaven Pharmaceutical Holding Company Ltd.4$150
Antares Pharma, Inc.8$147
Actelion Pharmaceuticals US, Inc.5$140
Biohaven Pharmaceuticals, Inc.3$131
Boehringer Ingelheim6$122
Phathom Pharmaceuticals, Inc.6$119
Amarin Pharma, Inc.7$104
Lilly USA, LLC4$90
Mallinckrodt Hospital Products Inc.4$89
Eisai Inc.3$70
Ultragenyx Pharmaceutical Inc.3$67
Sumitomo Pharma America, Inc.3$62
Sunovion Pharmaceuticals Inc.3$58
Kowa Pharmaceuticals America, Inc.3$48
Harmony Biosciences LLC1$48
Sanofi1$46
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$44
Verona Pharma, Inc.2$44
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$41
Shield Therapeutics Inc2$39
Idorsia Pharmaceuticals US Inc2$39
Biogen2$38
Acerus Pharmaceuticals Corporation3$37
Merck2$34
Sun Pharmaceutical Industries Inc.1$30
Dexcom, Inc.1$30
Scpharmaceuticals Inc.2$28
Bridgebio Pharma, Inc.1$27
Jazz Pharmaceuticals Inc.1$25
Medicomp Inc1$24
Baxter Healthcare1$22
Gilead1$22
Insmed, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$21
Grifols USA, LLC1$19
Bayer1$17
Lexicon Pharmaceuticals, Inc.1$17
Genentech USA, Inc.1$17
Halozyme Inc1$16
Melinta Therapeutics, LLC1$14
Biomerieux Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,761 in reported general payments places this provider in the 95th percentile of 222 family medicine providers in Rhode Island.

See all family medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$42,260
Medicare patients
200
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban84$97,718
Trelegy ElliptaFluticasone/Umeclidin/Vilanter99$71,020
OzempicSemaglutide39$44,904
JardianceEmpagliflozin36$44,107
XareltoRivaroxaban16$25,092
VraylarCariprazine Hcl12$18,048
EntrestoSacubitril/Valsartan17$17,347
LinzessLinaclotide18$16,810
TrulicityDulaglutide11$12,747
MyrbetriqMirabegron18$11,145
TradjentaLinagliptin19$9,202
Atorvastatin Calcium846$8,466
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,423
GemtesaVibegron13$6,202
Omeprazole350$5,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,324$97,71884 claims
GSKTrelegy Ellipta, Breo Ellipta$1,333$75,936117 claims
Boehringer IngelheimJardiance, Tradjenta$122$53,30955 claims
Novo NordiskOzempic$405$44,90439 claims
AbbVieVraylar, Linzess, Lumigan$1,981$37,90541 claims
Johnson & JohnsonXarelto$1,600$25,09216 claims
NovartisEntresto$491$17,34717 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,534$12,90032 claims
Lilly USA, LLCTrulicity$90$12,74711 claims
Astellas Pharma US IncMyrbetriq$299$11,14518 claims
Sumitomo Pharma America, Inc.Gemtesa$62$6,20213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 222 family medicine providers in Rhode Island.

Other family medicine in Johnston

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →